Medication Assisted Treatment (MAT) Buprenorphine, Norbuprenorphine, and Naloxone MS Confirmation, Urine
Also known as: Opioid Use Disorder, Suboxone™ MAT, Suboxone™ MAT, Opioid Use Disorder, Buprenorphine/Norbuprenorphine, Naloxone
Use
Detect and confirm presence of prescribed and illicit drugs for monitoring Suboxone™/buprenorphine medication assisted treatment (MAT). Please note: This testing is designed specifically for monitoring patients who are on Suboxone™/buprenorphine only. This testing should not be used for monitoring chronic pain patients (medical drug monitoring) or methadone medication assisted treatment.
Special Instructions
Not provided.
Limitations
The performance characteristics of some components of this panel were determined by Labcorp and have not been cleared or approved by the FDA. This testing should not be used for other medication monitoring such as chronic pain management or methadone treatment.
Methodology
Mass Spectrometry
Biomarkers
Buprenorphine
AnalyteNaloxone
AnalyteNorbuprenorphine
Analyte
LOINC Codes
- 19150-2 - Acceptable Creat Ur Ql
- 3414-0 - Buprenorphine Ur Ql
- 58360-9 - Buprenorphine/Creat Ur
- 58361-7 - Norbuprenorphine/Creat Ur
- 77207-9 - Naloxone Ur Cfm-mCnc
Result Turnaround Time
4-7 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
3 mL
Container
Plastic urine container or transfer tube without preservative
Storage Instructions
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.
Causes for Rejection
Urine from preservative tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 6 weeks |
Other tests from different labs that may be relevant